New study ties weight-loss drugs Wegovy, Ozempic to serious gastrointestinal conditions

Medicines in the same class as popular weight-loss therapies Ozempic and Wegovy may carry an increased risk of pancreatitis, intestinal blockage and stomach paralysis compared to an older obesity drug, Canadian researchers find.